吴祥猛, 盛莉, 贾雨霏, 李燕. 乳腺癌耐药蛋白在药物代谢动力学中的作用J. 药学学报, 2016,51(9): 1368-1377. doi: 10.16438/j.0513-4870.2016-0199
引用本文: 吴祥猛, 盛莉, 贾雨霏, 李燕. 乳腺癌耐药蛋白在药物代谢动力学中的作用J. 药学学报, 2016,51(9): 1368-1377. doi: 10.16438/j.0513-4870.2016-0199
WU Xiang-meng, SHENG Li, JIA Yu-fei, LI Yan. Role of breast cancer resistance protein in drug dispositionJ. Acta Pharmaceutica Sinica, 2016,51(9): 1368-1377. doi: 10.16438/j.0513-4870.2016-0199
Citation: WU Xiang-meng, SHENG Li, JIA Yu-fei, LI Yan. Role of breast cancer resistance protein in drug dispositionJ. Acta Pharmaceutica Sinica, 2016,51(9): 1368-1377. doi: 10.16438/j.0513-4870.2016-0199

乳腺癌耐药蛋白在药物代谢动力学中的作用

Role of breast cancer resistance protein in drug disposition

  • 摘要: 乳腺癌耐药蛋白(BCRP)是体内重要的跨膜外排转运体,属于ATP结合盒转运体超家族,主要负责将内、外源性物质排至细胞外。BCRP体内分布广泛,胎盘、小肠、血脑屏障、肾小管等重要组织中均有表达,是介导药物-药物相互作用及临床用药个体差异的重要因素之一。本文就BCRP转运体的发现、生理功能和转运机制、底物和抑制剂以及对药物代谢动力学特征的影响等方面进行总结,以期为药物转运体BCRP与药物代谢动力学的研究提供借鉴。

     

    Abstract: Human breast cancer resistance protein (BCRP), an ATP-binding cassette (ABC) efflux transporter, is mainly responsible for the transport of many endogenous and xenobiotics. BCRP is expressed in different tissues, such as placental, intestinal epithelium, endothelial cells of brain microvessels, and renal proximal tubular cells. BCRP is considered as one of the key factor for the drug-drug interaction and individual difference in drug therapy. The review will provide an overview of the current knowledge on the discovery of BCRP and its physical function, transport mechanism, substrate and inhibitors, as well as its effect on the drug pharmacokinetics.

     

/

返回文章
返回